T-Cell Lymphoma Pipeline Insight Analysis Report 2024 - Regulatory Support Drives Fast-Track Development of Novel T Cell Lymphoma Drugs from Eisai, Takeda, and Rhizen Pharmaceuticals
November 06, 2024 04:59 ET
|
Research and Markets
Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "T-Cell Lymphoma Pipeline Insight Analysis Report" drug pipelines has been added to ResearchAndMarkets.com's offering.T-Cell lymphoma is a type of...